Highest-materiality recent filing
Aimei Health receives Nasdaq delisting notices for MVLS and MVPHS below thresholds
On Aug 21, 2026, Nasdaq notified Aimei that Market Value of Listed Securities (MVLS) was below $50M for 30 consecutive business days.
Termination effective July 7, 2026, due to failure to close by the outside date under Section 9.1(b).
Aimei Health receives Nasdaq delisting notice for delayed Q1 10-Q
Notice received on May 19, 2026 for failure to file Q1 10-Q due May 15, 2026.
Aimei Health receives Nasdaq delisting notice for late 10-K filing
Nasdaq notified Aimei on April 17, 2026 of non-compliance with Listing Rule 5250(c)(1) due to overdue Annual Report for FY2025.
Aimei Health extends business combination deadline to May 6, 2026; issues $34k promissory note
Extension payment of $34,330.96 deposited into trust to extend deadline by one month to May 6, 2026 (seventeenth extension).
Aimei Health shareholders approve extension; 3.94M shares redeemed for ~$44.8M, trust drops to $0.7M
Shareholders approved extending business combination deadline from Dec 6, 2025 to Dec 6, 2026.
Aimei Health shareholders approve business combination with United Hydrogen; 3.95M shares redeemed
Business Combination Proposal passed with 70.80% of votes cast in favor (3,832,573 for, 1,580,804 against).
Aimei Health extends business combination deadline to Dec 6, 2025 with $150K trust deposit
Deposited $150,000 into trust for 12th and final extension from Nov 6 to Dec 6, 2025.
Aimei Health (AFJK) issues $150K note for ninth trust extension to Sept 6, 2025
Extended deadline from Aug 6 to Sept 6, 2025; ninth of up to 12 allowed extensions.
Aimei Health SPAC extends deadline to March 6, 2025; shareholders redeem 2.9M shares for $31.3M
Shareholders approved amendments to allow monthly extensions at $150,000 for all public shares (down from per-share amounts).
Deposited $227,700 into trust to extend termination date from Jan. 6 to Feb. 6, 2025.
Aimei Health (AFJK) signs definitive merger agreement with United Hydrogen Group
Aimei Health (SPAC AFJK) entered into definitive Business Combination Agreement with United Hydrogen Group Inc. on June 19, 2024.
Aimei Health Technology closes IPO of 6.9M units at $10.00, raising $69M; $69.7M placed in trust
IPO of 6,900,000 units at $10.00/unit, including full over-allotment; gross proceeds $69M.
On April 15, 2024, Juan Fernandez Pascual tendered to the board of directors of Aimei Health Technology Co., Ltd. (the “ Company ”) his resignation, effective as of that date, as Chief Executive Officer, Secretary and a director of the Company.
On April 19, 2024, the board of directors of the Company appointed Mr. Junheng Xie as the Chief Executive Officer, Secretary and a director of the Company with effect from April 15, 2024.
Max materiality 0.85 · Median 0.50 · Most common event other_material